Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,257-2,268 of 10,592
Drug study icon
CompletedNCT03902613

18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolarity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

Remote / online
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT07227181

2025 Animal Assisted Therapy

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AnxietyBehavioralFrom 18 Years to 99 Years
Countries
United States
Sponsor
Andrew Bernard
Condition
Anxiety
Drug study icon
CompletedNCT00312494

Ziprasidone With Either Lithium or Divalproex for Bipolarity

This study is completed in the United States. It is testing ziprasidone With Either Lithium or Divalproex for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Behavioral study icon
CompletedNCT03796936

3MDR to Treat PTSD With mTBI (3MDR)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralOver 18 Years
Countries
United States
Sponsor
Walter Reed National Military Medical Center
Condition
PTSD
Drug study icon
CompletedNCT03039192

Intranasal Esketamine for depression

This study is completed in the United States, in Bulgaria, in Estonia, .... It is testing intranasal Esketamine for depression.

In United States
Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, Bulgaria, Estonia, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

In United States
Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Behavioral study icon
CompletedNCT00018850

5HT3 Antagonism and Auditory Gating in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.